Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2016 | Mar 2016 | Dec 2015 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-66.6M | $-71.0M | $-61.7M | $-60.4M | $-64.7M | $-52.5M | $-47.5M | $-35.8M |
| Depreciation & Amortization | $247.0K | $208.0K | $208.0K | $199.0K | $189.0K | $180.0K | $189.0K | $159.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $28.7M | $29.5M | $21.7M | $25.0M | $28.2M | $20.1M | $16.4M | $10.4M |
| Net Cash from Operating Activities | $-30.8M | $-35.0M | $-33.2M | $-36.8M | $-34.4M | $-50.0M | $-53.3M | $-24.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.6M | $44.0K | $59.0K | $152.0K | $356.0K | $435.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | — |
| Net Change in Cash | $-20.4M | $46.7M | $8.0M | $-36.2M | $-95.6M | $116.9M | $10.3M | $-27.1M |
| Free Cash Flow | $-34.4M | $-35.1M | $-33.3M | $-37.0M | $-34.8M | $-50.5M | — | — |